Lancet Capital

Lancet Capital

A venture capital firm in Massachusetts that focuses on investing in biomedical technologies, bio-informatics, biopharmaceuticals, medical devices, medical information systems, medical therapeutics and diagnostic systems.

Lancet Capital is a venture capital firm in Massachusetts that focuses on investing in biomedical technologies, bio-informatics, biopharmaceuticals, medical devices, medical information systems, medical therapeutics and diagnostic systems. Founded 1998 in Cambridge, Massachusetts, United States by George Sing and William Golden. Its portfolio companies include Biodel and Stentor. Lancet invests in researchers, clinicians and entrepreneurs to commercialize innovative technologies in the biomedical field. It is an SBIC that is affiliated with an academic medical center and aims to commercialize technologies in the biomedical field.

Timeline

People

Name
Role
LinkedIn

George Sing

Managing Director & Co-Founder

William Golden

Managing Director & Co-Founder

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

Biodel

Noveome Biotherapeutics

Stentor

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.